Back
Vertex Pharmaceuticals Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
62
VRTX
Vertex Pharmaceuticals
Last Price:
488.19
Seasonality Move:
-1.44%
Buy
63
BMY
Bristol-Myers Squibb
Last Price:
50.03
Seasonality Move:
4.77%
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $485.37. The Score for VRTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $49.13. The Score for BMY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $485.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $49.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.13 | Sell |
| Relative Strength Index (14 RSI): | 55.04 | Buy |
| Chaikin Money Flow: | 565555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (469.79 - 486.79) | Buy |
| Bollinger Bands (100): | (435.95 - 494.03) | Buy |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 55.01 | Buy |
| Chaikin Money Flow: | 8910088 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.92 - 49.68) | Buy |
| Bollinger Bands (100): | (41.35 - 48.01) | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 474.46 | Buy |
| 20-day SMA: | 480.66 | Buy |
| 50-day SMA: | 483.27 | Buy |
| 200-day SMA: | 437.3 | Buy |
| 8-day EMA: | 477.84 | Buy |
| 20-day EMA: | 478.82 | Buy |
| 50-day EMA: | 477.2 | Buy |
| 200-day EMA: | 439.16 | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.03 | Buy |
| 20-day SMA: | 48.98 | Buy |
| 50-day SMA: | 46.58 | Buy |
| 200-day SMA: | 47.72 | Buy |
| 8-day EMA: | 48.93 | Buy |
| 20-day EMA: | 48.7 | Buy |
| 50-day EMA: | 47.26 | Buy |
| 200-day EMA: | 48.77 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $1.22 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.24 per share, a decrease this year of $6.64 per share, and an increase next year of $6.24 per share.
Vertex Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||